EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of prevaccination blood and T-cell phenotypes on antibody responses to a COVID-19 mRNA vaccine

Yu Hidaka iD, Norihide Jo, Osamu Kikuchi, Masaru Fukahori, Takeshi Sawada, Yutaka Shimazu iD, Masaki Yamamoto, Kohei Kometani, Miki Nagao, Takako E Nakajima, Manabu Muto iD, Satoshi Morita und 1 weitere

International Immunology · 2025

DOI: 10.1093/intimm/dxaf013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, 2025. Verfasst von Yu Hidaka und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antibodies, Viral, COVID-19 Vaccines. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, iPS Cell Research Fund, COVID-19 Private Fund to the Shinya Yamanaka Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the high effectiveness of the coronavirus disease 2019 (COVID-19) mRNA vaccines, both immunogenicity and reactogenicity show substantial interindividual variability. One key challenge is predicting high and low responders using easily measurable parameters. In this study, we performed multivariate linear regression analysis, which allows adjustment for confounding, to explore independent predictive factors for antibody responses. Using data from 216 healthy vaccinated donors aged 23–81 years, we evaluated baseline characteristics, prevaccination blood and T-cell phenotypes, and post-vaccination T-cell responses as variables, with anti-receptor-binding domain (RBD) immunoglobulin G (IgG) titers following two doses of BNT162b2 vaccination as the primary outcome. Consistent with previous reports, higher age, a history of allergic disease, and autoimmune disease were associated with lower peak IgG titers. Additionally, the frequencies of interferon-γ+ spike-specific CD4+ T cells (T-cell response) following the first vaccination strongly correlated with higher IgG responses, while those of pre-existing spike-reactive T cells showed no association with peak IgG titers. Furthermore, we identified lower percentages of naïve CD8+ T cells, lower hemoglobin levels, lower lymphocyte counts, and higher mean corpuscular volume as independent pre-vaccination predictors of lower peak IgG levels. Notably, the frequency of naïve CD8+ T cells showed a positive correlation with the peak IgG levels even in univariate analysis. These findings contribute to the individualized prediction of mRNA vaccine efficacy and may provide insights into the mechanisms underlying individual heterogeneity in immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Antibodies, ViralCOVID-19 VaccinesCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesHumansMiddle AgedAdultAgedMaleFemaleImmunoglobulin GBNT162 VaccineAged, 80 and overYoung AdultVaccinationSpike Glycoprotein, CoronavirusAntibody FormationmRNA VaccinesPhenotype

Stichwörter der Autor:innen

SARS-CoV-2immunogenicitymultivariate linear regression analysisprediction of vaccine responsevaccine efficacy

Substanzen

Antibodies, ViralImmunoglobulin GBNT162 VaccineCOVID-19 VaccinesSpike Glycoprotein, CoronavirusmRNA Vaccines

Autor:innen und Institutionen

  • Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Alliance Laboratory for Advanced Medical Research, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Medical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Clinical Bio-Resource Center, Kyoto University Hospital, Kyoto, Japan.
  • Center for Cancer Immunotherapy and Immunobiology, Kyoto University, Kyoto, Japan.

ORCID-Profile: Yu Hidaka, Yutaka Shimazu, Manabu Muto, Yoko Hamazaki

Förderung

  • Japan Agency for Medical Research and Development
  • iPS Cell Research Fund
  • COVID-19 Private Fund to the Shinya Yamanaka Laboratory
  • CiRA
  • Kyoto University
  • Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)
  • Japan Society for the Promotion of Science
  • Kansai Economic Federation

Zitieren

APA

Hidaka, Y., Jo, N., Kikuchi, O., Fukahori, M., Sawada, T., Shimazu, Y., Yamamoto, M., Kometani, K., Nagao, M., Nakajima, T. E., Muto, M., Morita, S., & Hamazaki, Y. (2025). Effect of prevaccination blood and T-cell phenotypes on antibody responses to a COVID-19 mRNA vaccine. International Immunology. https://doi.org/10.1093/intimm/dxaf013

Vancouver

Hidaka Y, Jo N, Kikuchi O, Fukahori M, Sawada T, Shimazu Y, et al. Effect of prevaccination blood and T-cell phenotypes on antibody responses to a COVID-19 mRNA vaccine. International Immunology. 2025. doi:10.1093/intimm/dxaf013

BibTeX
@article{Hidaka2025,
  author = {Hidaka, Yu and Jo, Norihide and Kikuchi, Osamu and Fukahori, Masaru and Sawada, Takeshi and Shimazu, Yutaka and Yamamoto, Masaki and Kometani, Kohei and Nagao, Miki and Nakajima, Takako E and Muto, Manabu and Morita, Satoshi and Hamazaki, Yoko},
  title = {Effect of prevaccination blood and T-cell phenotypes on antibody responses to a COVID-19 mRNA vaccine},
  journal = {International Immunology},
  year = {2025},
  doi = {10.1093/intimm/dxaf013}
}
Kostenlos starten →